Ovensa
Aurora
About Ovensa
Ovensa provides nanomedicine technology platforms, which deliver targeted oral therapy with mucosal and brain-barrier crossing properties. Ovensa focuses on developing personalized treatments for cancer and neurodegenerative diseases and on preventing antibiotic resistance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.9M
- Funding stage: Seed
- Last round: Seed (Sep 2017)
- Website: ovensa.com
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ovensa-130289 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.